Biomedical Engineering Reference
In-Depth Information
456. Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res. 2006;98
(2):186-91.
457. Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O, et al. Endothelial
dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
Circulation. 2003;108(8):933-8.
458. Stuhlinger MC, Stanger O. Asymmetric dimethyl-L-arginine (ADMA): a possible link
between homocyst(e)ine and endothelial dysfunction. Curr Drug Metab. 2005;6(1):3-14.
459. Ogawa T, Kimoto M, Sasaoka K. Occurrence of a new enzyme catalyzing the direct
conversion of NG, NG-dimethyl-L-arginine to L-citrulline in rats. Biochem Biophys Res
Commun. 1987;148(2):671-7.
460. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the
nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104
(21):2569-75.
461. Rocha MS, Teerlink T, Janssen MC, Kluijtmans LA, Smulders Y, Jakobs C, et al. Asymmet-
ric dimethylarginine in adults with cystathionine beta-synthase deficiency. Atherosclerosis.
2012;222(2):509-11.
462. Frey D, Braun O, Briand C, Vasak M, Grutter MG. Structure of the mammalian NOS
regulator dimethylarginine dimethylaminohydrolase: a basis for the design of specific
inhibitors. Structure. 2006;14(5):901-11.
463. Reuben DM, Bruice TC. Reaction of thiol anions with benzene oxide and malachite green. J
Am Chem Soc. 1976;98(1):114-21.